# EScitalopram PIndolol ONset of Action

> **NCT01219686** · PHASE2,PHASE3 · TERMINATED · sponsor: **Markus KOSEL** · enrollment: 18 (actual)

## Conditions studied

- Unipolar Depression

## Interventions

- **DRUG:** escitalopram, pindolol
- **DRUG:** escitalopram
- **DRUG:** escitalopram

## Key facts

- **NCT ID:** NCT01219686
- **Lead sponsor:** Markus KOSEL
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2013-04
- **Final completion:** 2013-06
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Recruitment difficulties
- **Last updated:** 2015-05-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01219686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01219686, "EScitalopram PIndolol ONset of Action". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01219686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*